Company Analysis
Sign in

Biodexa Pharmaceuticals plc American Depositary Shs (BDRX)

Nasdaq: BDRX · Pharmaceutical Preparations · Cardiff · filing with the SEC since 2015
Full chart Alerts Compare
Grade4.1
◀ Past 3.0● Present 3.9▶ Future 5.0
3 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

Income statement, as filed

In thousands of pounds sterling (GBP), as filed; per-share figures in pounds sterling; share counts. The fiscal year ends in December.
Income statement, by fiscal year, newest first
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period endingDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019Dec 31, 2018Dec 31, 2017Dec 31, 2016
Report filedMar 27, 2026Apr 11, 2025Apr 19, 2024Apr 28, 2023Apr 26, 2022Apr 30, 2021Jun 15, 2020Apr 30, 2019Apr 24, 2018Apr 6, 2017
Revenue··3816995783436741,938989r1,323r
Cost of revenue········926667
Gross profit········6,6726,256
Research and development3,9615,4374,0675,1114,6546,0687,8439,3598,329r7,730r
Sales and marketing·····6323·170r12,510
General and administrative4,8363,7934,3424,5422,9464,958r3,8414,3944,266r3,245r
Total operating expenses········14,26525,429
Operating income-8,645-9,199-8,014-8,932-6,998-23,040-11,318-11,815-13,276r-9,652r
Finance costs2291654153444319758716673
Finance income2,3853,385570497936149224151,337
Income before income taxes-6,489-5,979-7,485-8,488-6,106-23,470-10,923-12,400-12,970r-8,388r
Income tax expense-105-250-406-832-646r-1,2811,785r-2,032-1,265-2,227r
Income from continuing operations-6,384-5,729-7,079-7,656-5,460-22,189-9,138-10,368-11,705-6,161
Income from discontinued operations······-947-4,662-4,359-14,001
Net income-6,384-5,729-7,079-7,656-5,460-22,189-10,085-15,030-16,064-20,162
Earnings per share, basic-0.0001-0.001-0.02-1.55······
Earnings per share, diluted-0.0001-0.001-0.02-1.55······
Earnings per share, basic and diluted········-12,400.00b-22,400.00b
Weighted average shares, basic54,861,066,2644,952,784,179315,849,6004,941,7934,027,345r2,142,000r18,330,588152,815rb128,293rb36,072,752
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.Share counts and per-share figures are on the newest report's basis, after the 1-for-20 reverse split.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it soldifrs-full:Revenue
Cost of revenue what it cost to make or buy what it soldifrs-full:CostOfSales
Gross profit revenue less the cost of what it soldifrs-full:GrossProfit
Research and development spent on inventing what it sells nextifrs-full:ResearchAndDevelopmentExpense
Sales and marketing the cost of finding and serving customersifrs-full:SalesAndMarketingExpense
General and administrative the cost of running the company itselfifrs-full:AdministrativeExpense
Total operating expenses the running costs togetherifrs-full:OperatingExpense
Operating income profit from running the business, before interest and taxifrs-full:ProfitLossFromOperatingActivities
Finance costs what its borrowing costifrs-full:FinanceCosts
Finance income what its cash and investments earnedifrs-full:FinanceIncome
Income before income taxes profit before taxifrs-full:ProfitLossBeforeTax
Income tax expense tax charged on the period's profitifrs-full:IncomeTaxExpenseContinuingOperations
Income from continuing operations profit from the businesses it keepsifrs-full:ProfitLossFromContinuingOperations
Income from discontinued operations profit or loss from businesses it sold or closedifrs-full:ProfitLossFromDiscontinuedOperations
Net income the whole group's profit, minority holders' share includedifrs-full:ProfitLoss
Earnings per share, basic net income per share outstandingifrs-full:BasicEarningsLossPerShare
Earnings per share, diluted net income per share, counting every share that could be issuedifrs-full:DilutedEarningsLossPerShare
Earnings per share, basic and diluted net income per share, where both counts are the sameifrs-full:BasicAndDilutedEarningsLossPerShare
Weighted average shares, basic the average count of shares outstandingifrs-full:WeightedAverageShares
SI Assistanton BDRX · research, not advice